Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Journal of Receptor and Signal Transduction Research|February 19, 2020
Quantitative and qualitative analysis of integrin subtype expression in melanocytes and melanoma cellsVerena Kopatz, Edgar SelzerExpert Review of Clinical Pharmacology|October 30, 2013
Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developmentsEdgar Selzer, Gabriela KornekWiener Medizinische Wochenschrift (1946)|April 6, 2012
Basic principles of molecular effects of irradiationEdgar Selzer, Alexandra HebarCurrent Pharmaceutical Design|January 20, 2009
Targeted therapies in solid tumours: pinpointing the tumour's Achilles heelGabriela Kornek, Edgar SelzerWiener Medizinische Wochenschrift (1946)|June 19, 2008
[Organ sparing treatment modalities - which type of treatment for which carcinoma?]Gabriela Verena Kornek, Edgar SelzerActa Crystallographica. Section E, Structure Reports Online|March 12, 2013
4-({(Z)-5-[(Z)-3-Eth-oxy-4-hy-droxy-benzyl-idene]-3-methyl-4-oxo-1,3-thia-zolidin-2-yl-idene}amino)-benzoic acid dimethyl-formamide monosolvatePaul Kosma, Edgar Selzer, Kurt MereiterExpert Review of Clinical Pharmacology|January 1, 2013
The impact of molecular targets in cancer drug development: major hurdles and future strategiesAlexandra Hebar, Peter Valent, Edgar SelzerPlos One|October 3, 2012
NVX-412, a new oncology drug candidate, induces S-phase arrest and DNA damage in cancer cells in a p53-independent mannerAlexandra Hebar, Barbara C Rütgen, Edgar SelzerOral Oncology|August 18, 2016
Neoadjuvant radiotherapy plus radical surgery for locally advanced stage III/IV oral cancer: Analysis of prognostic factors affecting overall survivalChristina Eder-Czembirek, Cornelia Czembirek, Edgar SelzerWiener Klinische Wochenschrift|February 28, 2016
Pre-therapeutic fibrinogen levels are of prognostic significance in locally advanced head and neck cancerEdgar Selzer, Anja Grah, Gregor Heiduschka, et al.Pageof 7